176 related articles for article (PubMed ID: 31117832)
1. Design and synthesis of novel pyrazolo[4,3-
Wang BS; Huang X; Chen LZ; Liu MM; Shi JB
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1121-1130. PubMed ID: 31117832
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.
Somakala K; Tariq S; Amir M
Bioorg Chem; 2019 Jun; 87():550-559. PubMed ID: 30928877
[TBL] [Abstract][Full Text] [Related]
3. Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis.
Chen LZ; Shu HY; Wu J; Yu YL; Ma D; Huang X; Liu MM; Liu XH; Shi JB
Eur J Med Chem; 2021 Mar; 213():113174. PubMed ID: 33515864
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and structure-activity relationship studies of 4-indole-2-arylaminopyrimidine derivatives as anti-inflammatory agents for acute lung injury.
Chen T; Wei Y; Zhu G; Zhao H; Zhang X
Eur J Med Chem; 2021 Dec; 225():113766. PubMed ID: 34425313
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory action of Athyrium multidentatum extract suppresses the LPS-induced TLR4 signaling pathway.
Han XZ; Ma R; Chen Q; Jin X; Jin YZ; An RB; Piao XM; Lian ML; Quan LH; Jiang J
J Ethnopharmacol; 2018 May; 217():220-227. PubMed ID: 29476961
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and SAR study of novel 4,5-dihydropyrazole-Thiazole derivatives with anti-inflammatory activities for the treatment of sepsis.
Zhang Z; Cao P; Fang M; Zou T; Han J; Duan Y; Xu H; Yang X; Li QS
Eur J Med Chem; 2021 Dec; 225():113743. PubMed ID: 34403978
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents.
Zhang Y; Luo L; Han C; Lv H; Chen D; Shen G; Wu K; Pan S; Ye F
Molecules; 2017 Nov; 22(11):. PubMed ID: 29137170
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel 2-sulfonylindoles as potential anti-inflammatory therapeutic agents for treatment of acute lung injury.
Xia Q; Bao X; Sun C; Wu D; Rong X; Liu Z; Gu Y; Zhou J; Liang G
Eur J Med Chem; 2018 Dec; 160():120-132. PubMed ID: 30326372
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
Yuan L; Song C; Li C; Li Y; Dong L; Yin S
Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new disubstituted benzoxazolone derivatives that act as iNOS inhibitors with potent anti-inflammatory activity against LPS-induced acute lung injury (ALI).
Tang L; Gao XH; Zhao B; Luo JR; Shi XY; Ge R; Ban SR; Li QS
Bioorg Med Chem; 2020 Nov; 28(21):115733. PubMed ID: 33065432
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Structure-Activity Relationship Analysis of Thiazolo[3,2-a]pyrimidine Derivatives with Anti-inflammatory Activity in Acute Lung Injury.
Chen L; Jin Y; Fu W; Xiao S; Feng C; Fang B; Gu Y; Li C; Zhao Y; Liu Z; Liang G
ChemMedChem; 2017 Jul; 12(13):1022-1032. PubMed ID: 28503918
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities.
Abd El Razik HA; Mroueh M; Faour WH; Shebaby WN; Daher CF; Ashour HMA; Ragab HM
Chem Biol Drug Des; 2017 Jul; 90(1):83-96. PubMed ID: 28032452
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of new phthalimides as potential anti-inflammatory agents.
Bach DH; Liu JY; Kim WK; Hong JY; Park SH; Kim D; Qin SN; Luu TT; Park HJ; Xu YN; Lee SK
Bioorg Med Chem; 2017 Jul; 25(13):3396-3405. PubMed ID: 28478865
[TBL] [Abstract][Full Text] [Related]
15. EGFR inhibitors from cancer to inflammation: Discovery of 4-fluoro-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide as a novel anti-inflammatory EGFR inhibitor.
Elkamhawy A; Hassan AHE; Paik S; Sup Lee Y; Lee HH; Shin JS; Lee KT; Roh EJ
Bioorg Chem; 2019 May; 86():112-118. PubMed ID: 30685642
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of stem bark of Paulownia tomentosa Steud. in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and LPS-induced murine model of acute lung injury.
Lee JW; Seo KH; Ryu HW; Yuk HJ; Park HA; Lim Y; Ahn KS; Oh SR
J Ethnopharmacol; 2018 Jan; 210():23-30. PubMed ID: 28843892
[TBL] [Abstract][Full Text] [Related]
17. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
[TBL] [Abstract][Full Text] [Related]
18. A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
Shim DW; Shin HJ; Han JW; Ji YE; Jang CH; Koppula S; Kang TB; Lee KH
Toxicol Appl Pharmacol; 2015 Apr; 284(2):227-35. PubMed ID: 25689174
[TBL] [Abstract][Full Text] [Related]
19. Novel Pyrazolo[4,3- d]pyrimidine as Potent and Orally Active Inducible Nitric Oxide Synthase (iNOS) Dimerization Inhibitor with Efficacy in Rheumatoid Arthritis Mouse Model.
Shi JB; Chen LZ; Wang BS; Huang X; Jiao MM; Liu MM; Tang WJ; Liu XH
J Med Chem; 2019 Apr; 62(8):4013-4031. PubMed ID: 30925056
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.
Yang LL; Li GB; Ma S; Zou C; Zhou S; Sun QZ; Cheng C; Chen X; Wang LJ; Feng S; Li LL; Yang SY
J Med Chem; 2013 Feb; 56(4):1641-55. PubMed ID: 23362959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
